{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:55Z","timestamp":1787032855256,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,26]]},"DOI":"10.7759\/cureus.51109","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T08:01:30Z","timestamp":1703577690000},"source":"Crossref","is-referenced-by-count":2,"title":["Machine Learning Insights Into Uric Acid Elevation With Thiazide Therapy Commencement and Intensification"],"prefix":"10.7759","author":[{"given":"Murat","family":"\u00d6zdede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper T","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3434","article-title":"Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome","volume":"4","author":"Lanaspa MA","year":"2013","unstructured":"Lanaspa MA, Ishimoto T, Li N, et al.. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun. 2013, 4:2434. 10.1038\/ncomms3434","journal-title":"Nat Commun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-0481-6","article-title":"Uric acid and hypertension","volume":"43","author":"Lanaspa MA","year":"2020","unstructured":"Lanaspa MA, Andres-Hernando A, Kuwabara M. Uric acid and hypertension. Hypertens Res. 2020, 43:832-834. 10.1038\/s41440-020-0481-6","journal-title":"Hypertens Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","article-title":"Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk","volume":"79","author":"Borghi C","year":"2022","unstructured":"Borghi C, Agnoletti D, Cicero AF, Lurbe E, Virdis A. Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022, 79:1927-1936. 10.1161\/HYPERTENSIONAHA.122.17956","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000701","article-title":"Serum uric acid and the risk of cardiovascular and renal disease","volume":"33","author":"Borghi C","year":"2015","unstructured":"Borghi C, Rosei EA, Bardin T, et al.. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015, 33:1729-1741. 10.1097\/HJH.0000000000000701","journal-title":"J Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10370","article-title":"Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study","volume":"71","author":"Kuwabara M","year":"2018","unstructured":"Kuwabara M, Hisatome I, Niwa K, et al.. Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study. Hypertension. 2018, 71:78-86. 10.1161\/HYPERTENSIONAHA.117.10370","journal-title":"Hypertension"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-018-0095-4","article-title":"Effects of uric acid on vascular endothelial function from bedside to bench","volume":"41","author":"Otani N","year":"2018","unstructured":"Otani N, Toyoda S, Sakuma M, et al.. Effects of uric acid on vascular endothelial function from bedside to bench. Hypertens Res. 2018, 41:923-931. 10.1038\/s41440-018-0095-4","journal-title":"Hypertens Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092509","article-title":"Uric acid and vascular damage in essential hypertension: role of insulin resistance","volume":"12","author":"Cassano V","year":"2020","unstructured":"Cassano V, Crescibene D, Hribal ML, et al.. Uric acid and vascular damage in essential hypertension: role of insulin resistance. Nutrients. 2020, 12:2509. 10.3390\/nu12092509","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"Lanaspa MA","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al.. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012, 287:40732-40744. 10.1074\/jbc.M112.399899","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11496","article-title":"Uric acid and hypertension because of arterial stiffness","volume":"72","author":"Kuwabara M","year":"2018","unstructured":"Kuwabara M, Kanbay M, Hisatome I. Uric acid and hypertension because of arterial stiffness. Hypertension. 2018, 72:582-584. 10.1161\/HYPERTENSIONAHA.118.11496","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.21618","article-title":"Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis","volume":"3","author":"Wei J","year":"2020","unstructured":"Wei J, Galaviz KI, Kowalski AJ, Magee MJ, Haw JS, Narayan KM, Ali MK. Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis. JAMA Netw Open. 2020, 3:e1921618. 10.1001\/jamanetworkopen.2019.21618","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003368","article-title":"Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials","volume":"41","author":"Chalmers J","year":"2023","unstructured":"Chalmers J, Mourad JJ, Brzozowska-Villatte R, De Champvallins M, Mancia G. Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials. J Hypertens. 2023, 41:508-515. 10.1097\/HJH.0000000000003368","journal-title":"J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","article-title":"Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis","volume":"65","author":"Olde Engberink RH","year":"2015","unstructured":"Olde Engberink RH, Frenkel WJ, van den Bogaard B, Brewster LM, Vogt L, van den Born BJ. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension. 2015, 65:1033-1040. 10.1161\/HYPERTENSIONAHA.114.05122","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia G","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, et al.. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023, 41:1874-2071. 10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-1215-z","article-title":"Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"19","author":"Rahimi-Sakak F","year":"2019","unstructured":"Rahimi-Sakak F, Maroofi M, Rahmani J, Bellissimo N, Hekmatdoost A. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. BMC Cardiovasc Disord. 2019, 19:218. 10.1186\/s12872-019-1215-z","journal-title":"BMC Cardiovasc Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5457","article-title":"Hyperuricemia associated with thiazide diuretics in hypertensive adults","volume":"11","author":"Raja R","year":"2019","unstructured":"Raja R, Kavita F, Amreek F, Shah A, Sayeed KA, Sehar A. Hyperuricemia associated with thiazide diuretics in hypertensive adults. Cureus. 2019, 11:e5457. 10.7759\/cureus.5457","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.05.021","article-title":"Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction","volume":"114","author":"G\u00fcven AT","year":"2023","unstructured":"G\u00fcven AT, \u00d6zdede M, \u015eener YZ, et al.. Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction. Eur J Intern Med. 2023, 114:74-83. 10.1016\/j.ejim.2023.05.021","journal-title":"Eur J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01953-z","article-title":"Efficacy of different urinary uric acid indicators in patients with chronic kidney disease","volume":"21","author":"Guan H","year":"2020","unstructured":"Guan H, Zheng Y, Zhou X, Xu Y, Fu C, Xiao J, Ye Z. Efficacy of different urinary uric acid indicators in patients with chronic kidney disease. BMC Nephrol. 2020, 21:290. 10.1186\/s12882-020-01953-z","journal-title":"BMC Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000082551","article-title":"Uric acid elimination in the urine. Pathophysiological implications","volume":"147","author":"Marangella M","year":"2005","unstructured":"Marangella M. Uric acid elimination in the urine. Pathophysiological implications. Contrib Nephrol. 2005, 147:132-148. 10.1159\/000082551","journal-title":"Contrib Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00012.2017","article-title":"Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2","volume":"313","author":"Toyoki D","year":"2017","unstructured":"Toyoki D, Shibata S, Kuribayashi-Okuma E, Xu N, Ishizawa K, Hosoyamada M, Uchida S. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiol-Renal Physiol. 2017, 313:826-834. 10.1152\/ajprenal.00012.2017","journal-title":"Am J Physiol-Renal Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1995.268.1.E1","article-title":"Effect of insulin on uric acid excretion in humans","volume":"268","author":"Qui\u00f1ones Galvan A","year":"1995","unstructured":"Qui\u00f1ones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E. Effect of insulin on uric acid excretion in humans. Am J Physiol-Endocrinol Metab. 1995, 268:1-5. 10.1152\/ajpendo.1995.268.1.E1","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11728","article-title":"Role of insulin-mediated antinatriuresis in sodium homeostasis and hypertension","volume":"72","author":"Brands MW","year":"2018","unstructured":"Brands MW. Role of insulin-mediated antinatriuresis in sodium homeostasis and hypertension. Hypertension. 2018, 72:1255-1262. 10.1161\/HYPERTENSIONAHA.118.11728","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.78.1.8288709","article-title":"Hyperuricemia and insulin resistance","volume":"78","author":"Vuorinen-Markkola H","year":"1994","unstructured":"Vuorinen-Markkola H, Yki-J\u00e4rvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994, 78:25-29. 10.1210\/jcem.78.1.8288709","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3242-0","article-title":"Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients","volume":"35","author":"Perez-Ruiz F","year":"2015","unstructured":"Perez-Ruiz F, Aniel-Quiroga MA, Herrero-Beites AM, Chinchilla SP, Erauskin GG, Merriman T. Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients. Rheumatol Int. 2015, 35:1519-1524. 10.1007\/s00296-015-3242-0","journal-title":"Rheumatol Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(02)02953-9","article-title":"Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent","volume":"15","author":"Tsunoda S","year":"2002","unstructured":"Tsunoda S, Kamide K, Minami J, Kawano Y. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens. 2002, 15:697-701. 10.1016\/s0895-7061(02)02953-9","journal-title":"Am J Hypertens"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu Y","year":"2014","unstructured":"Zhu Y, Hu Y, Huang T, et al.. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014, 447:707-714. 10.1016\/j.bbrc.2014.04.080","journal-title":"Biochem Biophys Res Commun"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.4310","article-title":"The effects of allopurinol on the carotid intima-media thickness in patients with type 2 diabetes and asymptomatic hyperuricemia: a three-year randomized parallel-controlled study","volume":"54","author":"Liu P","year":"2015","unstructured":"Liu P, Wang H, Zhang F, Chen Y, Wang D, Wang Y. The effects of allopurinol on the carotid intima-media thickness in patients with type 2 diabetes and asymptomatic hyperuricemia: a three-year randomized parallel-controlled study. Intern Med. 2015, 54:2129-2137. 10.2169\/internalmedicine.54.4310","journal-title":"Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/JIM.0000000000000242","article-title":"Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia","volume":"63","author":"Takir M","year":"2015","unstructured":"Takir M, Kostek O, Ozkok A, et al.. Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia. J Investig Med. 2015, 63:924-929. 10.1097\/JIM.0000000000000242","journal-title":"J Investig Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3612-2","article-title":"Effects of febuxostat on insulin resistance and expression of high-sensitivity C-reactive protein in patients with primary gout","volume":"37","author":"Meng J","year":"2017","unstructured":"Meng J, Li Y, Yuan X, Lu Y. Effects of febuxostat on insulin resistance and expression of high-sensitivity C-reactive protein in patients with primary gout. Rheumatol Int. 2017, 37:299-303. 10.1007\/s00296-016-3612-2","journal-title":"Rheumatol Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2019.05.003","article-title":"Redox regulation of metabolic syndrome: recent developments in skeletal muscle insulin resistance and non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Yeo YH","year":"2019","unstructured":"Yeo YH, Lai YC. Redox regulation of metabolic syndrome: recent developments in skeletal muscle insulin resistance and non-alcoholic fatty liver disease (NAFLD). Curr Opin Physiol. 2019, 9:79-86. 10.1016\/j.cophys.2019.05.003","journal-title":"Curr Opin Physiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2007.5.2.62","article-title":"Effects of increased uric acid intake on the abundance of urate-anion exchanger and organic anion transporter proteins in the rat kidney","volume":"5","author":"Kim S","year":"2007","unstructured":"Kim S, Lee CH, Kang CM, Kim GH. Effects of increased uric acid intake on the abundance of urate-anion exchanger and organic anion transporter proteins in the rat kidney. Electrolyte Blood Press. 2007, 5:62-67. 10.5049\/EBP.2007.5.2.62","journal-title":"Electrolyte Blood Press"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2011.09.009","article-title":"Metabolic complications associated with use of diuretics","volume":"31","author":"Palmer BF","year":"2011","unstructured":"Palmer BF. Metabolic complications associated with use of diuretics. Semin Nephrol. 2011, 31:542-552. 10.1016\/j.semnephrol.2011.09.009","journal-title":"Semin Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew293","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem C","year":"2017","unstructured":"Ben Salem C, Slim R, Fathallah N, Hmouda H. Drug-induced hyperuricaemia and gout. Rheumatology (Oxford). 2017, 56:679-688. 10.1093\/rheumatology\/kew293","journal-title":"Rheumatology (Oxford)"},{"key":"ref33","article-title":"Evidence for altered renal urate reabsorption during changes in volume of the extracellular fluid","volume":"74","author":"Steele TH","year":"1969","unstructured":"Steele TH. Evidence for altered renal urate reabsorption during changes in volume of the extracellular fluid. J Lab Clin Med. 1969, 74:288-299.","journal-title":"J Lab Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00310-6","article-title":"Ketone bodies for the starving heart","volume":"2","author":"Schulze PC","year":"2020","unstructured":"Schulze PC, Wu JM. Ketone bodies for the starving heart. Nat Metab. 2020, 2:1183-1185. 10.1038\/s42255-020-00310-6","journal-title":"Nat Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4644-9","article-title":"Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME\u00ae randomised trial","volume":"61","author":"Verma S","year":"2018","unstructured":"Verma S, Mazer CD, Fitchett D, Inzucchi SE, Pfarr E, George JT, Zinman B. Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME\u00ae randomised trial. Diabetologia. 2018, 61:1712-1723. 10.1007\/s00125-018-4644-9","journal-title":"Diabetologia"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002050","article-title":"The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Piperidou A","year":"2019","unstructured":"Piperidou A, Sarafidis P, Boutou A, et al.. The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019, 37:1334-1343. 10.1097\/HJH.0000000000002050","journal-title":"J Hypertens"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2018.11.013","article-title":"Effects of sodium glucose cotransporter-2 inhibitors on serum uric acid in type 2 diabetes mellitus: a systematic review with an indirect comparison meta-analysis","volume":"26","author":"Xin Y","year":"2019","unstructured":"Xin Y, Guo Y, Li Y, Ma Y, Li L, Jiang H. Effects of sodium glucose cotransporter-2 inhibitors on serum uric acid in type 2 diabetes mellitus: a systematic review with an indirect comparison meta-analysis. Saudi J Biol Sci. 2019, 26:421-426. 10.1016\/j.sjbs.2018.11.013","journal-title":"Saudi J Biol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12774","article-title":"Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension","volume":"9","author":"Kimura T","year":"2018","unstructured":"Kimura T, Sanada J, Shimoda M, et al.. Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension. J Diabetes Investig. 2018, 9:875-881. 10.1111\/jdi.12774","journal-title":"J Diabetes Investig"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00555.2014","article-title":"Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus","volume":"308","author":"Lytvyn Y","year":"2015","unstructured":"Lytvyn Y, \u0160krti\u0107 M, Yang GK, Yip PM, Perkins BA, Cherney DZ. Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol. 2015, 308:F77-F83. 10.1152\/ajprenal.00555.2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.616564","article-title":"Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule","volume":"30","author":"Jutabha P","year":"2011","unstructured":"Jutabha P, Anzai N, Wempe MF, Wakui S, Endou H, Sakurai H. Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule. Nucleosides Nucleotides Nucleic Acids. 2011, 30:1302-1311. 10.1080\/15257770.2011.616564","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/life12111891","article-title":"Altered serum uric acid levels in kidney disorders","volume":"12","author":"Kim GH","year":"2022","unstructured":"Kim GH, Jun JB. Altered serum uric acid levels in kidney disorders. Life (Basel). 2022, 12:1891. 10.3390\/life12111891","journal-title":"Life (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.12.023","article-title":"Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"43","author":"Athyros VG","year":"2004","unstructured":"Athyros VG, Elisaf M, Papageorgiou AA, et al.. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis. 2004, 43:589-599. 10.1053\/j.ajkd.2003.12.023","journal-title":"Am J Kidney Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.04.005","article-title":"Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia","volume":"148","author":"Milionis HJ","year":"2004","unstructured":"Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004, 148:635-640. 10.1016\/j.ahj.2004.04.005","journal-title":"Am Heart J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/15257771003741323","article-title":"Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients","volume":"29","author":"Ogata N","year":"2010","unstructured":"Ogata N, Fujimori S, Oka Y, Kaneko K. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleosides Nucleotides Nucleic Acids. 2010, 29:321-324. 10.1080\/15257771003741323","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C","article-title":"The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients","volume":"43","author":"Caspi D","year":"2000","unstructured":"Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000, 43:103-108. 10.1002\/1529-0131(200001)43:1&lt;103::AID-ANR13&gt;3.0.CO;2-C","journal-title":"Arthritis Rheum"},{"key":"ref46","article-title":"Renal effects of low dose aspirin in elderly patients","volume":"8","author":"Segal R","year":"2006","unstructured":"Segal R, Lubart E, Leibovitz A, Iaina A, Caspi D. Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J. 2006, 8:679-682.","journal-title":"Isr Med Assoc J"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202589","article-title":"Low-dose aspirin use and recurrent gout attacks","volume":"73","author":"Zhang Y","year":"2014","unstructured":"Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi H. Low-dose aspirin use and recurrent gout attacks. Ann Rheum Dis. 2014, 73:385-390. 10.1136\/annrheumdis-2012-202589","journal-title":"Ann Rheum Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate-anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto A","year":"2002","unstructured":"Enomoto A, Kimura H, Chairoungdua A, et al.. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature. 2002, 417:447-452. 10.1038\/nature742","journal-title":"Nature"},{"key":"ref49","article-title":"Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles","volume":"280","author":"Roch-Ramel F","year":"1997","unstructured":"Roch-Ramel F, Guisan B, Diezi J. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles. J Pharmacol Exp Ther. 1997, 280:839-845.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb03772.x","article-title":"A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide","volume":"31","author":"Elliott WJ","year":"1991","unstructured":"Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol. 1991, 31:751-757. 10.1002\/j.1552-4604.1991.tb03772.x","journal-title":"J Clin Pharmacol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2021.04.012","article-title":"Machine learning applications in nephrology: a bibliometric analysis comparing kidney studies to other medicine subspecialities","volume":"3","author":"Verma A","year":"2021","unstructured":"Verma A, Chitalia VC, Waikar SS, Kolachalama VB. Machine learning applications in nephrology: a bibliometric analysis comparing kidney studies to other medicine subspecialities. Kidney Med. 2021, 3:762-767. 10.1016\/j.xkme.2021.04.012","journal-title":"Kidney Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/212164-machine-learning-insights-into-uric-acid-elevation-with-thiazide-therapy-commencement-and-intensification","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:12:20Z","timestamp":1707491540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/212164-machine-learning-insights-into-uric-acid-elevation-with-thiazide-therapy-commencement-and-intensification"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.51109","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}